HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative in vivo studies of soluble simian virus 40 tumor-specific transplantation antigens of the mouse.

Abstract
Quantitative studies have been performed on the immunogenicity of a membrane-bound antigen of a simian virus 40 (SV40) -induced sarcoma in syngeneic BALB/c mice and of subcellular fractions derived from this tumor. The objectives of the investigation were: a) to develop a quantitative in vivo assay of the tumor-specific transplantation antigen (TSTA) and b) to compare the distribution of histocompatibility antigens, H-2, with that of the SV40 TSTA during several fractionation steps. The immunogenicity of the TSTA-containing fractions was assessed from dose-response curves relating tumor size and the amount of protein used for immunization. After digestion of the tumor cell membranes with a limited amount of papain, H-2 as well as TSTA were present in a soluble form. A single immunization with only 2 microng of the solubilized TSTA reduced the tumor size by 70% compared to that in nonimmunized control animals. The results of several fractionation steps suggest that H-2 and the TSTA are not tightly associated in the solubilized immunogenic material.
AuthorsO Henriksen, L W Law, E Appella
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 58 Issue 6 Pg. 1785-8 (Jun 1977) ISSN: 0027-8874 [Print] United States
PMID194045 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Histocompatibility Antigens
Topics
  • Animals
  • Antigens, Neoplasm (administration & dosage, analysis)
  • Cell Membrane (immunology)
  • Dose-Response Relationship, Immunologic
  • Female
  • Histocompatibility Antigens (analysis)
  • Mice
  • Mice, Inbred BALB C
  • Neoplasm Transplantation
  • Sarcoma, Experimental (immunology)
  • Simian virus 40 (immunology)
  • Transplantation, Isogeneic
  • Tumor Virus Infections (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: